Seeing Is Believing

Currently out of the existing stock ratings of Jason Kolbert, 768 are a BUY (96.6%), 27 are a HOLD (3.4%).
Analyst Jason Kolbert, currently employed at D. BORAL CAPITAL, carries an average stock price target met ratio of 35.22% that have a potential upside of 64.58% achieved within 320 days. Previously, Jason Kolbert worked at DAWSON JAMES.
Jason Kolbert’s has documented 1,414 price targets and ratings displayed on 92 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on ANIX, Anixa Biosciences at 30-Jun-2026.
Analyst best performing recommendations are on VNRX (VOLITIONRX LTD).
The best stock recommendation documented was for IVVD (INVIVYD) at 8/25/2025. The price target of $1 was fulfilled within 1 day with a profit of $0.44 (78.57%) receiving and performance score of 785.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 22-Mar-2022
4 years 5 months 8 days ago
(19-May-2022)
4/4 (100%)
$-43.45 (-97.75%)
1702
Hold Since 16-Nov-2020
$1.5
5 years 11 months 11 days ago
(16-Nov-2020)
2/2 (100%)
$-38.7 (-96.27%)
1340
Hold Since 26-Nov-2019
6 years 11 months 1 days ago
(26-Nov-2019)
1/1 (100%)
$-364 (-98.11%)
2030
Sell Since 23-Jul-2019
$77
7 years 3 months 4 days ago
(23-Jul-2019)
2/6 (33.33%)
$-12.6 (-14.06%)
9
$5
$4.51 (920.41%)
9 years 10 months 7 days ago
(20-Dec-2016)
1/1 (100%)
$-191 (-97.45%)
2327
Which stock is Jason Kolbert most bullish on?
Which stock is Jason Kolbert most reserved on?
What Year was the first public recommendation made by Jason Kolbert?